115 related articles for article (PubMed ID: 15467735)
1. HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1.
Hartman J; Müller P; Foster JS; Wimalasena J; Gustafsson JA; Ström A
Oncogene; 2004 Nov; 23(54):8826-33. PubMed ID: 15467735
[TBL] [Abstract][Full Text] [Related]
2. Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.
Hartman J; Lam EW; Gustafsson JA; Ström A
Breast Cancer Res; 2009; 11(6):R79. PubMed ID: 19891787
[TBL] [Abstract][Full Text] [Related]
3. The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression.
Muller P; Kietz S; Gustafsson JA; Strom A
J Biol Chem; 2002 Aug; 277(32):28376-9. PubMed ID: 12080040
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
[TBL] [Abstract][Full Text] [Related]
5. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
Zhang Y; Hamburger AW
J Biol Chem; 2004 Jun; 279(25):26126-33. PubMed ID: 15073182
[TBL] [Abstract][Full Text] [Related]
6. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
Wang W; Dong L; Saville B; Safe S
Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
[TBL] [Abstract][Full Text] [Related]
10. Cell context-dependent differences in the induction of E2F-1 gene expression by 17 beta-estradiol in MCF-7 and ZR-75 cells.
Ngwenya S; Safe S
Endocrinology; 2003 May; 144(5):1675-85. PubMed ID: 12697671
[TBL] [Abstract][Full Text] [Related]
11. E2F inhibits transcriptional activation by the retinoic acid receptor.
Costa SL; Pratt MA; McBurney MW
Cell Growth Differ; 1996 Nov; 7(11):1479-85. PubMed ID: 8930397
[TBL] [Abstract][Full Text] [Related]
12. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
Müller P; Crofts JD; Newman BS; Bridgewater LC; Lin CY; Gustafsson JA; Ström A
Breast Cancer Res Treat; 2010 Apr; 120(2):317-26. PubMed ID: 19322650
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
14. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
Yoshida K; Inoue I
Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
16. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor E2F controls the reversible gamma delta T cell growth arrest mediated through WC1.
Kirkham PA; Lam EW; Takamatsu HH; Parkhouse RM
J Immunol; 1998 Aug; 161(4):1630-6. PubMed ID: 9712024
[TBL] [Abstract][Full Text] [Related]
19. The Hairy and Enhancer of Split homologue-1 (HES-1) mediates the proliferative effect of 17beta-estradiol on breast cancer cell lines.
Ström A; Arai N; Leers J; Gustafsson JA
Oncogene; 2000 Nov; 19(51):5951-3. PubMed ID: 11127827
[TBL] [Abstract][Full Text] [Related]
20. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
